HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Business (Wellness)

Set Alert for Business {Wellness}


Set Alert for Deals {Wellness}

Latest From Wellness & Deals

Pierre Fabre Takes Stake In French Women's Health Start-Up

France's Pierre Fabre is enhancing its presence in the women's health market by taking a stake in dietary supplements and cosmetics firm MiYé.

Europe Deals

Clasado Adds 14 Markets To Bimuno’s Reach With Phytonet Partnership

A partnership with Swiss functional ingredients supplier Phytonet AG brings UK prebiotic specialist Clasado 14 steps closer to global coverage for Bimuno GOS. 

International Wellness

Cipla Grows South African OTC Offering With Actor Acquisition

Cipla has signaled its commitment to expanding its OTC offering with the acquisition of South Africa's Actor Pharma and its diversified consumer health portfolio.

South Africa Deals
See All


Set Alert for Business Strategy {Wellness}

Latest From Wellness & Business Strategies

US Health And Wellness Executive Decisions: Perrigo, Nestle, Flexpower Health, Herbalife, More

NBA star Antetokounmpo invests in Flexpower; Perrigo changes Americas helm; Bündchen models healthy lifestyle for Gaia; Vit-Best appoints growth chief; Olympian Jennings works with Protein Puck; and more.

Executive Changes Consumer

FTC On AI And Consumer Vulnerabilities: ‘One Self-Regulatory Failure Is Begetting Another’

The US FTC’s Sam Levine, director of the Bureau of Consumer Protection, discusses the advent of AI and the compounding risks consumers face in today’s evolving, largely unregulated, profoundly uncertain digital age.

Artificial Intelligence Business Strategies

Bausch + Lomb Spreads Into US Cosmetics Market, Extends Lumify Brand With Eye Illuminations Line

Canadian firm launches US sales of Lumify Eye Illuminations 3-in-1 Micellar Cleansing Water and Eye Makeup Remover, Nourishing Lash & Brow Serum and Hydra-Gel Brightening Eye Cream. Each product contains hyaluronic acid, a fluid in eyes and joints which acts as a cushion and lubricant.

Cosmetics Launches
See All

Sales & Earnings

Set Alert for Sales & Earnings {Wellness}

Latest From Wellness & Sales & Earnings

DSM-Firmenich Looks To Women's Health and Postbiotics As Immunity Demand Remains Weak

To counteract falling sales due to weaker immunity supplement demand post-pandemic, ingredients firm DSM-Firmenich is investing in innovation in the increasingly popular women's health and postbiotics product categories. 

Dietary Supplements Ingredients

Growth In China Helps Swisse Supplements Hit AU$1bn Sales Milestone

Australian heritage dietary supplements brand Swisse achieved a significant sales milestone in the first half of 2023 reflecting growing demand for its products, particularly in China.

Asia Pacific International

Dermapharm Benefits From Supplements Demand And Arkopharma Acquisition

Germany's Dermapharm said strong global demand for dietary supplements, in combination with its acquisition of herbals specialist Arkopharma, had helped drive up sales in the first half of 2023.

Europe Health
See All


Set Alert for Legal Issues

Latest From Wellness & Legal Issues

FTC Health Claims Guidance ‘Lacks Legal Basis,’ Conflicts With FDA’s Supplement Regulations – CRN

“There is no bright-line requirement that a company possess randomized, controlled clinical studies before making so-called ‘health benefit’ claims for dietary supplements,” CRN states in petition. FTC, however, says it “makes no bright-line distinctions between categories of health-related products or claims.”

Ad Complaints Consumer

‘Akin To Junk Mail,’ FTC Notices Of Penalty Offense Don't Identify Health Claim Violations – Petition

Trade group ask FTC to withdraw notices, arguing it is attempting to impose substantiation standard prohibited under FDA regulations for supplement manufacturing and marketing and are inconsistent with its own as well as FDA guidance

Ad Complaints Dietary Supplements

Wheat, Hi-Tech On Hook For $40M As Appeals Court Rejects Argument Against FTC Authority

“The defendants’ argument rests on a misunderstanding of the basis for the contempt judgment” which were “imposed because the defendants violated the injunction,” says three-judge 11th Circuit panel.

Dietary Supplements Legal Issues
See All